The document provides an overview of methods for screening anti-epileptic drugs, including both in vivo and in vitro techniques. It summarizes several common in vivo models used to test drug efficacy, such as the maximal electroshock seizure test and chemically induced seizure models using pentylentetrazol or pilocarpine. It also describes in vitro methods like hippocampal brain slice recordings and receptor binding assays that can be used to study drug mechanisms of action. The document aims to explain techniques for evaluating new compounds and understanding the basic mechanisms of established anti-epileptic medications.
Preclinical screening methods of cns stimulantsRashmi116
This document describes various preclinical screening methods used to evaluate central nervous system (CNS) stimulants. It discusses behavioral manifestations of CNS stimulation like increased alertness. Various screening methods are described including the actophotometer test to measure locomotor activity, strychnine-induced convulsion test, sand displacement test, runway test and others. Each test is briefly explained along with its purpose, procedure, and evaluation method. A variety of behavioral tests in animals are used to screen for CNS stimulant activity of novel compounds.
This document discusses various in vitro and in vivo models for screening antipsychotic drugs. It begins by providing background on schizophrenia and antipsychotic drugs. It then describes two important in vitro models - the D1 receptor assay using 3H-SCH 23390 binding and the D2 receptor assay using 3H spiroperidol binding. Both assays are used to determine binding affinity of test compounds to dopamine receptors. Three key in vivo models are also outlined - the open field test to evaluate motor activity, the rota rod test to assess motor coordination, and the grip strength test to measure muscular strength. The document provides details on the procedures and evaluation of these screening models.
Screening Model of Anti-diarrheal activity.pptxRushikeshTidake
This document summarizes screening models used to test anti-diarrheal activity. It describes in vivo models using castor oil or magnesium sulfate to induce diarrhea in rats, and evaluates test compounds' ability to reduce defecation rate and fluid accumulation. It also describes an in vitro cecectomized rat model where carbachol or cholera toxin induce diarrhea, and test compounds are evaluated for their ability to reduce fecal output and prolong the diarrhea-free period. The document concludes by stating dose-response curves can be obtained to evaluate a test compound's ability to decrease hyper-secretion and prolong the diarrhea-free period in these screening models.
The document summarizes various screening methods used to evaluate immunomodulators. It discusses in vivo methods like acute systemic anaphylaxis in rats and delayed type hypersensitivity reaction in rats. It also discusses in vitro methods like inhibition of histamine release from mast cells and neutrophil locomotion assays. The document provides details of various protocols used for screening immunomodulators.
This document summarizes models used to study anti-emetic drugs. It describes various in vivo, in vitro, and human models. For in vivo models, it outlines drug-induced (cisplatin, apomorphine, copper sulfate), motion, and radiation models using species like dogs, cats, ferrets, and rats. It discusses parameters assessed like retching episodes. For in vitro models, it notes evaluating drugs' activity at 5-HT3 receptors. Finally, it mentions human models like using apomorphine or ipecac to induce vomiting and assessing drug effectiveness.
This document summarizes various preclinical screening methods used to evaluate potential anti-epileptic drugs. It describes several animal models of induced seizures including electroshock seizures, chemical-induced seizures using pentylenetetrazol or picrotoxin. It also discusses genetic models like the totterer mouse that is prone to spontaneous seizures. The key methods are maximal electroshock in mice/rats to test generalized tonic-clonic seizure protection and the pentylenetetrazol test in mice to assess anticonvulsant effects against petit mal-like seizures. These preclinical tests aim to predict potential efficacy of new compounds before clinical trials in humans.
This document describes various methods for screening anti-anginal drugs, including both in vivo and in vitro techniques. The isolated heart (Langendorff) preparation is discussed in detail, where a heart is removed and retrogradely perfused to evaluate drug effects on contractility, coronary flow, and other parameters. The isolated heart-lung preparation and coronary artery ligation in isolated rat hearts are also presented as options to study anti-anginal drugs and model ischemia/reperfusion. Various evaluation criteria are provided such as measurements of left ventricular pressure, contractility, coronary flow, and more.
Preclinical screening methods of cns stimulantsRashmi116
This document describes various preclinical screening methods used to evaluate central nervous system (CNS) stimulants. It discusses behavioral manifestations of CNS stimulation like increased alertness. Various screening methods are described including the actophotometer test to measure locomotor activity, strychnine-induced convulsion test, sand displacement test, runway test and others. Each test is briefly explained along with its purpose, procedure, and evaluation method. A variety of behavioral tests in animals are used to screen for CNS stimulant activity of novel compounds.
This document discusses various in vitro and in vivo models for screening antipsychotic drugs. It begins by providing background on schizophrenia and antipsychotic drugs. It then describes two important in vitro models - the D1 receptor assay using 3H-SCH 23390 binding and the D2 receptor assay using 3H spiroperidol binding. Both assays are used to determine binding affinity of test compounds to dopamine receptors. Three key in vivo models are also outlined - the open field test to evaluate motor activity, the rota rod test to assess motor coordination, and the grip strength test to measure muscular strength. The document provides details on the procedures and evaluation of these screening models.
Screening Model of Anti-diarrheal activity.pptxRushikeshTidake
This document summarizes screening models used to test anti-diarrheal activity. It describes in vivo models using castor oil or magnesium sulfate to induce diarrhea in rats, and evaluates test compounds' ability to reduce defecation rate and fluid accumulation. It also describes an in vitro cecectomized rat model where carbachol or cholera toxin induce diarrhea, and test compounds are evaluated for their ability to reduce fecal output and prolong the diarrhea-free period. The document concludes by stating dose-response curves can be obtained to evaluate a test compound's ability to decrease hyper-secretion and prolong the diarrhea-free period in these screening models.
The document summarizes various screening methods used to evaluate immunomodulators. It discusses in vivo methods like acute systemic anaphylaxis in rats and delayed type hypersensitivity reaction in rats. It also discusses in vitro methods like inhibition of histamine release from mast cells and neutrophil locomotion assays. The document provides details of various protocols used for screening immunomodulators.
This document summarizes models used to study anti-emetic drugs. It describes various in vivo, in vitro, and human models. For in vivo models, it outlines drug-induced (cisplatin, apomorphine, copper sulfate), motion, and radiation models using species like dogs, cats, ferrets, and rats. It discusses parameters assessed like retching episodes. For in vitro models, it notes evaluating drugs' activity at 5-HT3 receptors. Finally, it mentions human models like using apomorphine or ipecac to induce vomiting and assessing drug effectiveness.
This document summarizes various preclinical screening methods used to evaluate potential anti-epileptic drugs. It describes several animal models of induced seizures including electroshock seizures, chemical-induced seizures using pentylenetetrazol or picrotoxin. It also discusses genetic models like the totterer mouse that is prone to spontaneous seizures. The key methods are maximal electroshock in mice/rats to test generalized tonic-clonic seizure protection and the pentylenetetrazol test in mice to assess anticonvulsant effects against petit mal-like seizures. These preclinical tests aim to predict potential efficacy of new compounds before clinical trials in humans.
This document describes various methods for screening anti-anginal drugs, including both in vivo and in vitro techniques. The isolated heart (Langendorff) preparation is discussed in detail, where a heart is removed and retrogradely perfused to evaluate drug effects on contractility, coronary flow, and other parameters. The isolated heart-lung preparation and coronary artery ligation in isolated rat hearts are also presented as options to study anti-anginal drugs and model ischemia/reperfusion. Various evaluation criteria are provided such as measurements of left ventricular pressure, contractility, coronary flow, and more.
This document discusses screening methods for antihypertensive agents. It begins with an introduction on hypertension and its prevalence. It then discusses various animal models used to study hypertension including spontaneous hypertensive rats. It provides details on several in vivo and in vitro screening models for inducing and studying hypertension including acute renal hypertension in rats, chronic renal hypertension in rats and dogs, and genetic hypertension in rats. It describes procedures, evaluations, and modifications of these methods. The goal is to utilize animal models that replicate features of human hypertension to screen for new antihypertensive agents.
The document discusses various screening methods for evaluating potential anxiolytic drugs, including in vitro receptor binding assays and in vivo behavioral tests in animals like the elevated plus maze test, light-dark box test, and social interaction test, which measure anxiety-like behaviors that can be reduced by anxiolytic drug administration. Classification of anxiolytics and theories of anxiety involving neurotransmitters like GABA, serotonin and norepinephrine are also covered.
This document summarizes several preclinical models used to screen anxiolytic agents. It describes anxiety disorders and the goal of developing animal models that resemble human pathology. Several models are explained in detail, including the elevated plus maze test, light-dark exploration test, and social interaction test in rats. These tests measure anxiety-like behaviors in rodents and can determine if candidate drugs decrease inhibited behaviors. The document also reviews in vitro and in vivo methods for evaluating putative anxiolytics before clinical trials.
This document summarizes various in vitro and in vivo models used for anti-epileptic drug screening. The in vitro models described include tests measuring effects on GABA and glutamate receptors, transporters, and uptake/release. The in vivo models involve inducing seizures chemically or through focal lesions in rodents and examining effects of test compounds. Several genetic and transgenic animal models of epilepsy are also mentioned. The document provides details on procedures and evaluation methods for key screening tests involving GABA uptake/release in hippocampal slices and electroshock induction in mice.
The document describes several screening models used to evaluate the effects of drugs on behavioral and muscle coordination in animals. It discusses tests such as the open field test, hole board test, chimney test, grip strength, and rota rod method. These tests measure parameters like locomotor activity, exploration, muscle strength, and motor coordination. The results of these tests can provide information about a drug's effects and allow the calculation of values like ED50 doses for sedative, stimulant, and muscle relaxant drugs.
This document describes various in vivo and in vitro screening methods used to evaluate potential analgesic compounds. Some key in vivo methods include the tail flick test, hot plate test, and acetic acid-induced writhing test, which assess analgesic effects using thermal, mechanical, and chemical pain stimuli, respectively. Important in vitro assays involve measuring the inhibition of nociceptin, binding to opioid receptors, and inhibition of enkephalinase enzyme. The screening methods aim to distinguish between narcotic and non-narcotic analgesics and help identify new compounds for treating different pain states.
1. The document discusses various models used to study Alzheimer's disease, including both in vitro and in vivo models. It describes assays such as inhibitory avoidance, step-down avoidance, and scopolamine-induced amnesia in mice that are used to test drugs for improving memory and cognition.
2. The pathological hallmarks of Alzheimer's disease involve extracellular amyloid plaques, neurofibrillary tangles, and loss of cortical cholinergic neurons. Several genetic models have also been developed to study the disease.
3. A variety of screening models are used to evaluate potential pharmacological treatments for Alzheimer's disease and assess their ability to inhibit acetylcholinesterase activity, affect nicotinic receptors, or antagonize
This document summarizes screening methods for evaluating the antipyretic (fever-reducing) effects of drugs in animal models. It describes using the Brewer's yeast suspension method to induce fever in rats and rabbits, and then testing potential antipyretic drugs. Key points:
1) Drugs are given to fevered animals and temperatures recorded at intervals to see if drugs lower elevated body temperatures compared to controls.
2) Studies summarized evaluated antipyretic effects of extracts from Bauhinia racemosa and Gracilaria corticata seaweed in rats. Both produced significant antipyretic activity.
3) The rabbit model uses bacterial lipopolysaccharides to induce fever and tests
This document describes several methods for screening potential drugs for the treatment of Alzheimer's disease, both in vitro and in vivo. The in vitro methods include assays to measure inhibition of acetylcholinesterase and butyrylcholinesterase activities. The in vivo methods involve testing drugs in animal models of memory impairment induced by scopolamine or lesions, as well as passive and active avoidance tasks using rodents. Evaluation involves comparing latency times or percentages of inhibition between drug-treated and control groups.
Screening methods of immunomodulators by shivam diwakerShivam Diwaker
This document summarizes various screening methods used to evaluate potential immunomodulators. It describes 5 methods: 1) acute systemic anaphylaxis in rats, 2) anti-anaphylactic activity, 3) passive cutaneous anaphylaxis, 4) Arthus type immediate hypersensitivity, and 5) delayed type hypersensitivity. Each method is outlined, including the principles, procedures, evaluations, and potential modifications. The overall purpose is to evaluate candidate immunomodulators for their ability to suppress or stimulate immune responses.
Introduction to Screening Models of Anti-Atherosclerosis
Atherosclerosis, Screening models, In vitro models, In vivo models
Presented by
SHAIK FIRDOUS BANU
Department of Pharmacology
The document discusses screening methods for anxiolytics, both in vitro and in vivo. Some key in vitro methods mentioned are GABA and serotonin receptor binding assays. Important in vivo methods described include tests that evaluate anticonvulsant activity, effects on behavior like the elevated plus maze test and light-dark test in mice/rats, and tests for anxiety-like behaviors. The elevated plus maze test is described in detail, including how it works, parameters measured, and how anxiolytics increase open arm exploration. The light-dark test is also explained, noting how anxiolytics increase locomotion and chamber crossings in this test. Overall, the document provides an overview of approaches for screening potential anxi
An assignment in the subject "Pharmacological and Toxicological Screening", 1st year, M.Pharm, Pharmacology, 1st semester. This presentation provides a brief knowledge about Pre-clinical Screening, Hypertension, Its Types, Normal body mechanism in Hypertension, Screening Procedures, Animal models, Animal model criteria, various screening procedures and their evaluation, Recent discovery, Hypertension Facts, Recent Discovery and Treatment for Hypertension.
Screening of anti ulcer drugs - Dr Divya KrishnanDivya Krishnan
This document discusses screening models for anti-ulcer agents. It outlines the requirements for an ideal screening model, including that it should be simple, reproducible, induce characteristic ulcers, involve different mechanisms of ulceration, and not allow spontaneous healing. The document states that rats are the ideal animal for screening due to their continuous acid secretion and resemblance to human stomach anatomy and nutrition. Several animal models are described, including the Shay rat pylorus ligation model, drug-induced gastric ulcer models in rats, acetic acid-induced chronic ulcers in rats, stress-induced ulcers in rats, and histamine-induced duodenal ulcers in guinea pigs. Recent advances involving gastrin transgenic mice and H
This document provides information on screening models used to evaluate antipsychotic agents. It begins with definitions of key terms like antipsychotic drugs, psychosis, and schizophrenia. It then describes types of psychosis and common symptoms. The rest of the document details various in vitro and in vivo models used to screen antipsychotic drugs, including D1/D2 receptor assays, tests of catalepsy in rodents, foot shock-induced aggression, and inhibition of apomorphine climbing in mice. The models aim to reflect the mechanisms of action of antipsychotics and their effects on behaviors related to psychosis.
Preclinical screening of anti anginalsDekollu Suku
Angina pectoris is a type of heart disease caused by reduced blood flow to the heart muscle. There are three main types - stable, unstable, and Prinzmetal angina. Treatment includes medications like organic nitrates, beta-blockers, and calcium channel blockers. Several in vitro and in vivo models are used to screen for new anti-anginal drugs, including the Langendorff heart preparation, isolated rabbit aorta preparation, and myocardial ischemia models in rats. These models evaluate how drug candidates affect parameters like coronary blood flow, contractile force, and degree of tissue damage.
SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docxTUSHARUNDHAD3
SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docx
1.INTRODUCTION
2.LIPOPROTEIN
3.RISK FACTORS
4.DIETARY SOURCE OF 5.CHOLESTEROL
6.CLASSIFICATION OF ANTIHYPERLIPIDEMIC AGENT
7.SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT
(A) In Vivo Models:
1.Triton induced hyperlipidemia in Wistar rat
2.Cholesterol diet induced atherosclerosis in rabbits (High fat diet)
3.Hereditary hyperlipidemia in rabbits
4.Hypolipidemic activity in Syrian hamsters
5.Transgenic animal model
6.Hereditary hypercholesteremia in rats
7. IV lipid tolerance test in rat
8.Efect of HMG COA reduction inhibition in vivo
9.Fructose induce hyperglycemia in rat
10.Cholestylamine binding
(B) In Vitro Models:
1.Inhibition of isolated HMG COA reductase inhibitors
2.ACAT inhibitory model
Assignment on Preclinical Screening of ImmunomodulatorsDeepak Kumar
Preclinical studies involve testing drugs or treatments in animals before human trials. This document discusses various types of preclinical studies including in vitro, in vivo, in situ, and in silico experiments. It also describes methods to study immunomodulators including inhibition of histamine release from mast cells and mitogen-induced lymphocyte proliferation assays. Various in vivo models are outlined such as acute systemic anaphylaxis in rats and delayed type hypersensitivity tests.
The document describes several in vitro and in vivo methods used to study anti-allergic and anti-inflammatory drugs. In vitro methods include inhibition of histamine release from mast cells and inhibition of T cell proliferation. In vivo methods include a rat anaphylaxis model, guinea pig Schultz-Dale reaction, and passive cutaneous anaphylaxis in rats. One method involves sensitizing rats with ovalbumin, then challenging them to induce shock, which can be counteracted by test drugs. Another involves sensitizing guinea pigs to egg albumin to study contractions in response to ovalbumin.
Preclinical evaluation of anti-epileptic drugs involves testing in various animal models of seizures. Common models include electrically or chemically induced seizures using maximal electroshock, pentylenetetrazol, picrotoxin, or strychnine administration. The effects of potential drugs are assessed by changes in seizure threshold, pattern, EEG changes, or incidence. Chronic models involve kindling or post-status epilepticus models to evaluate drugs for spontaneous recurrent seizures. Various in vivo methods detailed assess drug effects on different seizure types and epilepsies.
This document summarizes several experimental seizure models used in pharmacology research. It describes generalized tonic-clonic seizure models like the maximal electroshock test and pentylenetetrazole-induced seizures. It also covers models for partial and absence seizures, including electrical kindling, kainic acid, and gamma-hydroxybutyrate administration. Various genetic models are also mentioned, such as photosensitive baboons and audiogenic seizure-prone mice strains. The document provides details on the methodology, typical seizures observed, and anti-seizure drugs found effective in each model.
This document discusses screening methods for antihypertensive agents. It begins with an introduction on hypertension and its prevalence. It then discusses various animal models used to study hypertension including spontaneous hypertensive rats. It provides details on several in vivo and in vitro screening models for inducing and studying hypertension including acute renal hypertension in rats, chronic renal hypertension in rats and dogs, and genetic hypertension in rats. It describes procedures, evaluations, and modifications of these methods. The goal is to utilize animal models that replicate features of human hypertension to screen for new antihypertensive agents.
The document discusses various screening methods for evaluating potential anxiolytic drugs, including in vitro receptor binding assays and in vivo behavioral tests in animals like the elevated plus maze test, light-dark box test, and social interaction test, which measure anxiety-like behaviors that can be reduced by anxiolytic drug administration. Classification of anxiolytics and theories of anxiety involving neurotransmitters like GABA, serotonin and norepinephrine are also covered.
This document summarizes several preclinical models used to screen anxiolytic agents. It describes anxiety disorders and the goal of developing animal models that resemble human pathology. Several models are explained in detail, including the elevated plus maze test, light-dark exploration test, and social interaction test in rats. These tests measure anxiety-like behaviors in rodents and can determine if candidate drugs decrease inhibited behaviors. The document also reviews in vitro and in vivo methods for evaluating putative anxiolytics before clinical trials.
This document summarizes various in vitro and in vivo models used for anti-epileptic drug screening. The in vitro models described include tests measuring effects on GABA and glutamate receptors, transporters, and uptake/release. The in vivo models involve inducing seizures chemically or through focal lesions in rodents and examining effects of test compounds. Several genetic and transgenic animal models of epilepsy are also mentioned. The document provides details on procedures and evaluation methods for key screening tests involving GABA uptake/release in hippocampal slices and electroshock induction in mice.
The document describes several screening models used to evaluate the effects of drugs on behavioral and muscle coordination in animals. It discusses tests such as the open field test, hole board test, chimney test, grip strength, and rota rod method. These tests measure parameters like locomotor activity, exploration, muscle strength, and motor coordination. The results of these tests can provide information about a drug's effects and allow the calculation of values like ED50 doses for sedative, stimulant, and muscle relaxant drugs.
This document describes various in vivo and in vitro screening methods used to evaluate potential analgesic compounds. Some key in vivo methods include the tail flick test, hot plate test, and acetic acid-induced writhing test, which assess analgesic effects using thermal, mechanical, and chemical pain stimuli, respectively. Important in vitro assays involve measuring the inhibition of nociceptin, binding to opioid receptors, and inhibition of enkephalinase enzyme. The screening methods aim to distinguish between narcotic and non-narcotic analgesics and help identify new compounds for treating different pain states.
1. The document discusses various models used to study Alzheimer's disease, including both in vitro and in vivo models. It describes assays such as inhibitory avoidance, step-down avoidance, and scopolamine-induced amnesia in mice that are used to test drugs for improving memory and cognition.
2. The pathological hallmarks of Alzheimer's disease involve extracellular amyloid plaques, neurofibrillary tangles, and loss of cortical cholinergic neurons. Several genetic models have also been developed to study the disease.
3. A variety of screening models are used to evaluate potential pharmacological treatments for Alzheimer's disease and assess their ability to inhibit acetylcholinesterase activity, affect nicotinic receptors, or antagonize
This document summarizes screening methods for evaluating the antipyretic (fever-reducing) effects of drugs in animal models. It describes using the Brewer's yeast suspension method to induce fever in rats and rabbits, and then testing potential antipyretic drugs. Key points:
1) Drugs are given to fevered animals and temperatures recorded at intervals to see if drugs lower elevated body temperatures compared to controls.
2) Studies summarized evaluated antipyretic effects of extracts from Bauhinia racemosa and Gracilaria corticata seaweed in rats. Both produced significant antipyretic activity.
3) The rabbit model uses bacterial lipopolysaccharides to induce fever and tests
This document describes several methods for screening potential drugs for the treatment of Alzheimer's disease, both in vitro and in vivo. The in vitro methods include assays to measure inhibition of acetylcholinesterase and butyrylcholinesterase activities. The in vivo methods involve testing drugs in animal models of memory impairment induced by scopolamine or lesions, as well as passive and active avoidance tasks using rodents. Evaluation involves comparing latency times or percentages of inhibition between drug-treated and control groups.
Screening methods of immunomodulators by shivam diwakerShivam Diwaker
This document summarizes various screening methods used to evaluate potential immunomodulators. It describes 5 methods: 1) acute systemic anaphylaxis in rats, 2) anti-anaphylactic activity, 3) passive cutaneous anaphylaxis, 4) Arthus type immediate hypersensitivity, and 5) delayed type hypersensitivity. Each method is outlined, including the principles, procedures, evaluations, and potential modifications. The overall purpose is to evaluate candidate immunomodulators for their ability to suppress or stimulate immune responses.
Introduction to Screening Models of Anti-Atherosclerosis
Atherosclerosis, Screening models, In vitro models, In vivo models
Presented by
SHAIK FIRDOUS BANU
Department of Pharmacology
The document discusses screening methods for anxiolytics, both in vitro and in vivo. Some key in vitro methods mentioned are GABA and serotonin receptor binding assays. Important in vivo methods described include tests that evaluate anticonvulsant activity, effects on behavior like the elevated plus maze test and light-dark test in mice/rats, and tests for anxiety-like behaviors. The elevated plus maze test is described in detail, including how it works, parameters measured, and how anxiolytics increase open arm exploration. The light-dark test is also explained, noting how anxiolytics increase locomotion and chamber crossings in this test. Overall, the document provides an overview of approaches for screening potential anxi
An assignment in the subject "Pharmacological and Toxicological Screening", 1st year, M.Pharm, Pharmacology, 1st semester. This presentation provides a brief knowledge about Pre-clinical Screening, Hypertension, Its Types, Normal body mechanism in Hypertension, Screening Procedures, Animal models, Animal model criteria, various screening procedures and their evaluation, Recent discovery, Hypertension Facts, Recent Discovery and Treatment for Hypertension.
Screening of anti ulcer drugs - Dr Divya KrishnanDivya Krishnan
This document discusses screening models for anti-ulcer agents. It outlines the requirements for an ideal screening model, including that it should be simple, reproducible, induce characteristic ulcers, involve different mechanisms of ulceration, and not allow spontaneous healing. The document states that rats are the ideal animal for screening due to their continuous acid secretion and resemblance to human stomach anatomy and nutrition. Several animal models are described, including the Shay rat pylorus ligation model, drug-induced gastric ulcer models in rats, acetic acid-induced chronic ulcers in rats, stress-induced ulcers in rats, and histamine-induced duodenal ulcers in guinea pigs. Recent advances involving gastrin transgenic mice and H
This document provides information on screening models used to evaluate antipsychotic agents. It begins with definitions of key terms like antipsychotic drugs, psychosis, and schizophrenia. It then describes types of psychosis and common symptoms. The rest of the document details various in vitro and in vivo models used to screen antipsychotic drugs, including D1/D2 receptor assays, tests of catalepsy in rodents, foot shock-induced aggression, and inhibition of apomorphine climbing in mice. The models aim to reflect the mechanisms of action of antipsychotics and their effects on behaviors related to psychosis.
Preclinical screening of anti anginalsDekollu Suku
Angina pectoris is a type of heart disease caused by reduced blood flow to the heart muscle. There are three main types - stable, unstable, and Prinzmetal angina. Treatment includes medications like organic nitrates, beta-blockers, and calcium channel blockers. Several in vitro and in vivo models are used to screen for new anti-anginal drugs, including the Langendorff heart preparation, isolated rabbit aorta preparation, and myocardial ischemia models in rats. These models evaluate how drug candidates affect parameters like coronary blood flow, contractile force, and degree of tissue damage.
SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docxTUSHARUNDHAD3
SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docx
1.INTRODUCTION
2.LIPOPROTEIN
3.RISK FACTORS
4.DIETARY SOURCE OF 5.CHOLESTEROL
6.CLASSIFICATION OF ANTIHYPERLIPIDEMIC AGENT
7.SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT
(A) In Vivo Models:
1.Triton induced hyperlipidemia in Wistar rat
2.Cholesterol diet induced atherosclerosis in rabbits (High fat diet)
3.Hereditary hyperlipidemia in rabbits
4.Hypolipidemic activity in Syrian hamsters
5.Transgenic animal model
6.Hereditary hypercholesteremia in rats
7. IV lipid tolerance test in rat
8.Efect of HMG COA reduction inhibition in vivo
9.Fructose induce hyperglycemia in rat
10.Cholestylamine binding
(B) In Vitro Models:
1.Inhibition of isolated HMG COA reductase inhibitors
2.ACAT inhibitory model
Assignment on Preclinical Screening of ImmunomodulatorsDeepak Kumar
Preclinical studies involve testing drugs or treatments in animals before human trials. This document discusses various types of preclinical studies including in vitro, in vivo, in situ, and in silico experiments. It also describes methods to study immunomodulators including inhibition of histamine release from mast cells and mitogen-induced lymphocyte proliferation assays. Various in vivo models are outlined such as acute systemic anaphylaxis in rats and delayed type hypersensitivity tests.
The document describes several in vitro and in vivo methods used to study anti-allergic and anti-inflammatory drugs. In vitro methods include inhibition of histamine release from mast cells and inhibition of T cell proliferation. In vivo methods include a rat anaphylaxis model, guinea pig Schultz-Dale reaction, and passive cutaneous anaphylaxis in rats. One method involves sensitizing rats with ovalbumin, then challenging them to induce shock, which can be counteracted by test drugs. Another involves sensitizing guinea pigs to egg albumin to study contractions in response to ovalbumin.
Preclinical evaluation of anti-epileptic drugs involves testing in various animal models of seizures. Common models include electrically or chemically induced seizures using maximal electroshock, pentylenetetrazol, picrotoxin, or strychnine administration. The effects of potential drugs are assessed by changes in seizure threshold, pattern, EEG changes, or incidence. Chronic models involve kindling or post-status epilepticus models to evaluate drugs for spontaneous recurrent seizures. Various in vivo methods detailed assess drug effects on different seizure types and epilepsies.
This document summarizes several experimental seizure models used in pharmacology research. It describes generalized tonic-clonic seizure models like the maximal electroshock test and pentylenetetrazole-induced seizures. It also covers models for partial and absence seizures, including electrical kindling, kainic acid, and gamma-hydroxybutyrate administration. Various genetic models are also mentioned, such as photosensitive baboons and audiogenic seizure-prone mice strains. The document provides details on the methodology, typical seizures observed, and anti-seizure drugs found effective in each model.
Determination of anticonvulsant activity of drugs using animal modelsDr. Nipa Mendapara
This document discusses methods for determining the anticonvulsant activity of drugs using animal models. It begins by defining seizures and epilepsy according to the International League Against Epilepsy. It then describes several in vivo and in vitro animal models used in screening for new anticonvulsant drugs, including the maximal electroshock seizure test, chemically-induced seizure models using substances like pentylenetetrazol or pilocarpine, kindling models, and genetic models using epileptic-prone animals. The goal of these tests is to evaluate a drug's ability to prevent or reduce electrically or chemically induced seizure activity and elucidate new targets for developing improved antiepileptic treatments.
This document summarizes several experimental animal models used to study seizures and epilepsy. It discusses:
1. Classification of seizures and characteristics of ideal seizure models.
2. Common generalized seizure models including maximal electroshock, pentylenetetrazole, and picrotoxin induced seizures.
3. Models of partial seizures including those induced by topical convulsants, electrical stimulation, and chronic metal implants.
4. Genetic models like photosensitive baboons and audiogenic seizure prone mice strains.
It provides details on methodology, evaluation, and drugs effective in each model. The document aims to describe preclinical tools used in anticonvulsant drug development and mechanistic epilepsy
This document discusses various animal models used to study epilepsy and evaluate potential new antiepileptic drugs. It describes models that induce seizures chemically or electrically, as well as genetic models with spontaneous seizures. The maximal electroshock seizure and pentylenetetrazol-induced seizure tests are commonly used for initial drug screening. Kindling models involve repeated subconvulsive stimulation to induce recurrent seizures and evaluate drugs' effects on epileptogenesis. No single model fully represents the spectrum of human epilepsy, so multiple models are needed to evaluate different aspects of potential new treatments.
Animal models for screening of antiepileptic drugs &kamal_1981
The document outlines screening methods for antiepileptic drugs and their recent advances. It discusses various in vivo and in vitro methods used to screen drugs for ability to prevent seizures induced electrically or chemically in animal models. Recent advances include newer drugs like lamotrigine, topiramate, felbamate, zonisamide, vigabatrin, tiagabine, gabapentin, lacosamide, and levetiracetam that target sodium channels, glutamate receptors, GABA receptors or uptake to suppress seizure activity.
This document provides information on epilepsy and its animal models. It begins with an introduction to epilepsy, including its definition as a seizure disorder caused by abnormal electrical activity in the brain. It then discusses the epidemiology and causes of epilepsy. The classification and clinical manifestations of epilepsy are explained. The pathophysiology and management of epilepsy are also covered. The second half of the document focuses on animal models of epilepsy. It describes various chemical-induced, metal-induced, and other convulsion models. It provides details on the principle, treatment protocols, advantages and disadvantages of models like pentylenetetrazol, bicuculline, strychnine, and penicillin induced convulsions. Overall, the document comprehensively
This document discusses anti-epileptic drugs and methods for evaluating potential new anti-seizure medications. It covers classification of seizures, common anti-epileptic drugs used to treat different seizure types, and pre-clinical models used including in vitro and in vivo animal models. Several chemical-induced seizure models are described like pentylenetetrazole, isoniazid, strychnine, and pilocarpine induced seizures. The goal of these pre-clinical tests is to observe drug effects on electrically or chemically induced seizures in animals to identify compounds that may be effective in treating human epilepsy.
This document provides an overview of animal models used to study anti-convulsant drugs. It discusses several chemical and electrical induced seizure models used in mice and rats, including pentylenetetrazol, picrotoxin, strychnine, bicuculline, electroshock, and lithium-pilocarpine induced status epilepticus. The models aim to mimic different types of human seizures and evaluate potential anti-convulsant drugs by measuring changes in seizure threshold, motor pattern, EEG patterns, and seizure incidence. Genetic models like totterer mice that spontaneously develop seizures are also described.
Screening methods of Anti epileptic drugs.
Different methods to induce Experimental epilepsy.
Physical and chemical types of screening model of epilepsy.
Pre clinical screening of anti epileptic drugsHinnaHamid1
This document provides an overview of preclinical methods used to evaluate potential anti-epileptic drugs. It discusses in vitro methods like receptor binding assays and electrical recordings from brain slices. In vivo methods described include seizure models using electrical stimulation or chemoconvulsants in animals as well as genetic and post-hypoxic models. Details are given on maximal electroshock testing in mice and the kindled rat seizure model to assess anticonvulsant effects. Common chemoconvulsant models involving pentylenetetrazol, strychnine and picrotoxin are also outlined.
This document discusses the approach to seizures in infants and children. It defines seizures, convulsions, and epilepsy. It covers classification of seizures, history taking, physical examination, investigations including EEG and imaging, acute management of seizures and status epilepticus, selection of antiepileptic drugs, and prognosis. The approach involves detailed history, examination, initial investigations and treatment, followed by further testing and long-term management depending on the underlying cause.
1. Status epilepticus is defined as a seizure lasting more than 5 minutes or recurrent seizures without recovery in between.
2. It can be generalized convulsive seizures or non-convulsive without motor symptoms but ongoing EEG seizure activity.
3. Treatment involves stabilizing the patient, identifying and treating the underlying cause, giving benzodiazepines as first line, then fosphenytoin, phenytoin, phenobarbital or levetiracetam if still seizing, with escalation to anesthetic drugs, coma or general anesthesia if refractory.
Screening models of antiepileptic and nootropic drugsHimikaRathi
This document provides information on various methods used to screen potential antiepileptic drugs. It discusses in vivo models like maximal electroshock induced seizures in mice, pentylenetetrazol induced convulsions, and strychnine induced convulsions. In vitro methods like receptor binding assays and electrical recordings from brain slices are also covered. Different types of induced seizures and animal models of epilepsy are described. The mechanisms of commonly used proconvulsant drugs like picrotoxin and mechanisms of action of antiepileptic drugs are briefly discussed. Various stages of the kindling model are defined.
Anticonvulsant effect of drugs by MES and PTZ methodMirzaAnwarBaig1
1) The document describes experiments to test the anticonvulsant effects of drugs using maximum electroshock (MES) and pentylene tetrazole (PTZ) induced seizure models in rats and mice.
2) The experiments involve pretreating animals with test drugs or saline followed by inducing seizures using MES or PTZ and measuring the time taken for different phases of seizures.
3) Results show that pretreatment with diphenyl hydantoin sodium increases the time taken for tonic extension phase of MES induced seizures, indicating its anticonvulsant activity.
- Generalized tonic-clonic status epilepticus (GCSE) is a condition that will likely not terminate rapidly or spontaneously and requires prompt medical intervention. It is defined as continuous seizure activity lasting more than 5 minutes in children over 5 years old.
- Prolonged GCSE can cause respiratory, hemodynamic, metabolic, and other systemic complications that increase the risk of mortality and neurological injury if not treated promptly. Initial treatment involves rapid-acting benzodiazepines followed by longer-acting anticonvulsants like phenytoin or phenobarbital.
pediatrics. epilepsy and seizures in children 8.pptArun170190
Epilepsy is a chronic neurological condition characterized by recurrent, unprovoked seizures. The majority of cases in children are idiopathic, though some may be caused by cerebral malformations, infections, tumors or other brain injuries. Seizures occur due to abnormal neuronal discharge in the brain. Children may experience generalized seizures affecting both hemispheres or focal seizures arising from one hemisphere. Treatment involves classification of seizure type and use of anti-seizure medications as monotherapy where possible. Status epilepticus is a medical emergency requiring urgent treatment to prevent brain damage. Intractable epilepsy requires re-evaluation of diagnosis, medication compliance, and consideration of alternative treatment options.
The document provides information on the pharmacology of antiepileptic drugs (AEDs). It discusses the basic mechanisms of seizures and epilepsy, including abnormal neuronal excitation and synchronization. It then covers the epidemiology and classification of seizure types. The mechanisms by which epilepsy develops, both acquired and genetic, are described. Finally, the document outlines the cellular targets of AEDs and examples of drugs that act on GABA, sodium channels, calcium channels and other targets to reduce neuronal excitability and seizures.
1. Convulsive status epilepticus has a bimodal distribution, peaking in children and the elderly, and has multiple potential causes including infections, strokes, alcohol withdrawal and brain injuries.
2. Mortality rates range from 10.5-28% and neurological sequelae occur in 11-16% of patients. Refractory status epilepticus is defined as continuing despite benzodiazepines and other anticonvulsants.
3. Treatment involves terminating seizures acutely with benzodiazepines like lorazepam and diazepam. For refractory cases, second line drugs like phenytoin, fosphenytoin, valproate, levetirac
Expt 12 Anticonvulsant effect of drugs by MES and PTZ methodMirza Anwar Baig
This document summarizes a study on the anticonvulsant effect of drugs using the maximum electroshock (MES) and pentylene tetrazole (PTZ) methods. It describes using albino rats or mice and pretreating them for 60 minutes with either a test drug like diphenyl hydantoin-Na or a saline control. The MES method uses electrodes to induce seizures resembling grand mal epilepsy, while PTZ induces seizures resembling petit mal epilepsy. The study procedure involves dividing pre-screened mice into groups, administering the test drug or saline, applying a shock after 1 hour, and recording the timing of seizure phases.
Mercurius is named after the roman god mercurius, the god of trade and science. The planet mercurius is named after the same god. Mercurius is sometimes called hydrargyrum, means ‘watery silver’. Its shine and colour are very similar to silver, but mercury is a fluid at room temperatures. The name quick silver is a translation of hydrargyrum, where the word quick describes its tendency to scatter away in all directions.
The droplets have a tendency to conglomerate to one big mass, but on being shaken they fall apart into countless little droplets again. It is used to ignite explosives, like mercury fulminate, the explosive character is one of its general themes.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
2. Overview
Objectives
Introduction
Types of screening
Different epilepsy/seizure models in vivo
In vitro methods
Recent advances
Summary
References
3. To Understand the basic MOA of anti-epileptic drugs.
Different animal models for epilepsy
In vivo/ vitro screening techniques
Different animal models for drug resistant epilepsy
4. Epilepsy: derived from greek
word “epilepsia” which means
“to seize” or “to hold”
Disorder characterized by
recurrent unprovoked seizure.
Seizure: Paroxysmal,
abnormal, excessive, hyper
synchronous discharges from
an aggregate of CNS neurons
5. • Common disorder – 0.5- 0.8% population
• Prevalence of active epilepsy: 5-10 per 1000
• Drug resistant epilepsy seen in 20 - 30% pts
14. Maximum Electroshock Seizure
(MES) Test
Threshold for maximal
electroconvulsions model
Kindled Rat seizure model
6 Hz Mouse model
15. • Useful for screening of drugs effective against primary
and secondary GTC
• Animals – rat or mice (8-10)
• Electric stimulation - of cornea or ear with constant
current at 50-60/sec
16. Method (MES)
Evaluation: Anti convulsant property is determined by calculation of ED50
for suppression of tonic hind limb extension.
Observe: Phase of tonic flexion of 1.5 seconds, followed by phase of tonic
extension of about 10seconds, followed by short clonic interval leading to
asphyxial death.
For constant current: 50 mA in mice, 150 mA in rats
Constant Voltage : 250V in mice, 750 V in rats
Electrical stimulation : 50-60 Hz, 0.2 sec corneal or ear electrode
17.
18. …..Maximal Electroshock Seizure(MES) Test
• Evaluation - Suppression of tonic hind limb
extension taken as a measure of efficacy of a drug
against GTC
• e.g: Phenytoin, CBZ, phenobarbitone, primidone
• Disadvantage: Do not give any clue regarding MOA
of the compound.
19. Aim: To determine the ability of a drug to alter seizure
threshold for tonic limb extension
Principle: Drugs effective in GTC Seizures ↑threshold
Animals:
For each stimulus intensity 8-10 mice (male), wt- 18-30
gm
20. Electrical stimulation : 50-60 Hz, 0.2 sec
(constant current or constant voltage)
corneal or ear electrode- 0.2 sec
Observe: Threshold is determined as the current
or voltage inducing hind limb extension in 50%
animals
Calculation : CC50 , CV50
Evaluation: Elevation of threshold by test drug is
taken as a measure of efficacy.
CC50= Current threshold
CV = Voltage threshold
21. Principle:
Process whereby repeated administration of an initial sub-
convulsive electric stimulus results in progressive intensification of
stimulus induced epileptic activity, culminating in generalized
seizures.
Anticonvulsants prevent kindling.
Animals- Female Sprague -Dawley rats; 270-400 gm.
23. During daily stimulation, seizure develops which
evolve through the following steps : RACINE
ö Class 1- Immobility, eye closure, twitching of vibrissae,
stereotypic sniffing.
ö Class 2- Facial clonus and head nodding
ö Class 3- facial clonus, head nodding and U/L forelimb
clonus (C/L to focus).
ö Class 4- Rearing, accompanied b/l forelimb clonus.
ö Class 5- Rearing with loss of balance and falling
accompanied by generalized clonic seizures
– If stimulation continued for few weeks, rats develop spontaneous
epileptic seizures.
24. • Fig. 1. The development of epileptogenesis and emergence of recurrent spontaneous seizures
in the kindling and status epilepticus models. Arrows indicate electrical stimulation in the
kindling model or the administration of chemical agents such as kainate and pilocarpine in
the status epilepticus model. In the kindling model (upper panel), repeated stimulation
triggers progressively stronger seizure responses. If stimulation stops when the animal has
reached the standard stage 5 criterion, spontaneous seizures will not develop. If kindling
stimulations continue, spontaneous seizures typically emerge after the induction of hundreds
of evoked seizures (“over-kindling”).
25. Test compound : given orally or I/P
Efficacy determined by
Seizure latency
Seizure severity
Seizure duration
26. • Merits :
a) Efficacy of drug against process of epileptogenesis &
against fully kindled state can be measured
b) Efficacy against Generalized seizures of kindled state
Kindled seizure and kindling process –
Phenobarbitone
Diazepam
Valproic acid
Kindled seizure –
Phenytoin
Carbamazepine
27. Mice are stimulated by
Low frequency (6 Hz) electroshock with
0.2 msec rectangular pulses
3 sec
Corneal electrodes
Result/ end point- Brief clonic convulsion with loss of
righting relexes /stunning behaviour for 10 sec or more
Use
Screening of Pharmacoresistant epilepsy
28.
29. Chemoconvulsants inducing
generalized seizures after
systemic administration:
PTZ, picrotoxin, penicillin
INH, pilocarpine
NMDA, strychnine
Chemoconvulsants inducing
focal seizures after central
administration:
Penicillin
kainic acid
PTZ
30. • Acts by antagonizing inhibitory GABA transmission
• PTZ is used for screening drugs effective absence
seizures
1) Threshold for clonic seizures after IV infusion of
PTZ
2) S.C injection of PTZ
31. ö Animal – 8-10 mice or rats
ö Dose: 1% PTZ
ö End point : Dose for the production of GTCS with
loss of righting reflex.
ö For petit mal seizures: Ethosuximide & valproate
32. Test group Control
Test drug injected
I.V
No drug
1% PTZ @ 0.3ml/min I.V. 1% PTZ @ 0.3ml/min I.V
Observation -1 hr in
separate plastic cage
Isolated jerk (1st twitch)
GTC with loss of righting reflex
Then maximal tonic clonic seizure
Mean dose of PTZ to
produce seizure-
threshold calculated
Mean dose of PTZ to
produce seizure -
threshold calculated
33. ö Drugs effective in petit mal
epilepsy
ö Ethosuximide
ö Valproate
ö Not effective – phenytoin, CBZ
34. Test group Control
Test drug injected
S.C
No drug
1% PTZ @ 80-100mg s.c 1% PTZ @ 80-100mg s.c
End Point : 1st clonic jerk lasting 5 sec
OR
1st clonic seizure with loss of righting
reflex
SC CD97 determined
30 min
Efficacy of a test drug as an anticonvulsant is measured by its
ED50 for suppression of clonic seizure.
35. • Reduces inhibition by
antagonizing effects of GABA
at its receptor.
• Drug : Penicillin G - 3 lac units/kg I/M.
• Results: Arrested activity, staring, myoclonus,oro-facial
twitching and GTCS, within 1 hr of injection
• This model is useful for screening of drugs in Absence
seizures.
Animal : Cat
36.
37. Topical or Intracerebral application of metals, chemicals- can lead to simple partial
seizures.
These models are useful for screening of antiepileptic drugs effective against these
seizures.
1) Cortically implanted metals
Aluminium hydroxide, cobalt powder or tungstic acid injection
2) Aluminium hydroxide gel model – MC used
Animal : monkey
Method : 4% gel injected into neocortex
After 1-2 months spontaneous recurrent simple partial seizures begin which persist
for years.
38. 3) Systemic focal epileptogenesis: model combines features of
focal and generalised epilepsy.
Animal: rats
Method:
• α-particles radiation
given to cerebrum
Destruction of the
blood brain barrier
• After 3-6 months
Inj. bicuculline
2mg/kg i.p
• Seizure is produced with
recurrent EEG spikes and
focal seizures
Last for weeks
Phenytoin, phenobarbitol, valproic
acid
40. • Represents true model for epilepsy
• Allow for genetic component of epilepsy
A) Photosensitive baboons (Papio papio):
ピ Intermittent lightening at frequency of 25 flashes/sec
ピ Seizures characterized by eyelid then face, body clonus,
followed by tonic clonic convulsions.
ピ Drugs effective are valproic acid, phenobarbital,
benzodiazepines
41. • 1) Audiogenic suceptible mice- sound induced
seizures:
ピ DBA/2J mice, an inbred strain of house mouse.
ピ Stimulus : Exposed to sudden loud sound 12-16 KHz.
ピ Result : Wild running followed by clonic convulsions,
tonic extension and respiratory arrest (60%) or full
recovery.
ピ Seizures prevented by valproic acid, phenobarbital,
phenytoin.
42. 2) Totterer mice – homozygous (tg/tg) strain
ö Prone to spontaneous epileptic seizures.
ö By 3-4 weeks they develop partial and absence
seizures.
ö Mostly seizures lasts for 15 min or longer.
ö Seizures blocked by ethosuximide,
phenobarbital & diazepam
43. 3) E1 mice
ö E1 mice exhibit Seizures in response to vestibular
stimulation like tossing and spinning.
ö Seizure manifestations – limb and face automatism like
chewing and salivation.
ö Serve as models for complex partial epilepsy with 2˚
generalization.
ö Phenytoin and phenobarbitone are effective.
44. 4) Quaking mice
ö C57BL/6J mutants with myelin defects, tremors, spontaneous
or stimulus induced myoclonic or GTC seizures.
ö Handling induces seizures in Quaking mice.
ö Phenytoin, phenobarbitone, carbamazepine & valproate
ö Useful for assessment of potential new anti convulsant drugs
effective against focal seizures in humans.
45. 1) Genetically epilepsy prone rats (GEPR):
Seizures can be stimulated by sound, hyperthermia,
chemicals and electricity.
For anti convulsant drug evaluation – the tonic clonic
component of the seizure is used.
2) Rats with spontaneously occurring Petit Mal
Epilepsy:
• 15-30% Sprague Dawley and wistar rats at 14-18 wks of
age exhibit spontaneous behavioural arrest and myoclonic
twitchings .
• Model for absence seizures
46. ö Seizures can be precipitated by
New environment, bright light,
audiogenic stimulation and
vigrous shaking the cages and
handling techniques.
ö Young animal 7-10 wks - For
Petit mal Epilepsy.
50. ö Hippocampus Involved in
generation of complex partial
seizures
ö Useful for studying
neurophysiological
mechanism of epilepsies.
ö Animal: rat , mouse, guinea
pig
51. Rat decapitated
Brain removed
0.5mm slice
using vibrotome
Holding chamber
warm saline(28o),
95% O2 & 5% CO2
Transferred to perspex
chamber & attached to its
bottom
Artificial CSF/ warm saline
Recording from
pyramidal neuron
are done by
micropipette
2 hr.
52. • Illustration of the collection of
hippocampal tissues. With some
practice, the following procedure
takes as little as 15 min from
decapitation of the animal to
placing the cultures in the
incubator. Brains are collected
and prepared (a-c), and
hippocampi are removed (d-f).
Once the tissue chopper is ready
(g), the hippocampi are chopped
(h), transferred to fresh dissection
medium (i), and slices are
separated (j). Ideal slices (k) have
a compact and clearly visible
dentate gyrus granule cell body
layer (D) and pyramidal neuron
cell body layers (CA3 and CA1).
Slices are then placed on tissue
culture inserts (l) for short-term or
long-term culture in a CO2
incubator.
53. Readings are taken by adding drugs to slice medium
and recording the
Spontaneous
Shock evoked repetitive firing of neurons.
Advantage:
•Mechanical stability
•No BBB
•No anaesthetic agent
54. Isolated brain cells (hippocampus or hypothalamus) are used
for testing action of
Effect of drug on ion channels in excitable cell membranes
by using Patch clamp techniques
Use
Voltage sensitive Ca and K channels
Membrane response to NT
Basic mechanism of anti epileptic drugs can be devised
55. 1. GABA receptor binding assay to evaluate
compounds with GABAergic properties
a. GABAA receptor binding assay
To examine the GABAA binding sites
Muscimol (agonist) & SR 95531 (antagonist) are used as
radioligands
b. GABAB receptor binding assay
Baclofen (agonist)
56. 2) GABA uptake in rat cerebral cortex
Blocking uptake of GABA by GAT-1 inhibitors tiagabine,
nipecotic acid, guvacine and THPO exhibit anti-convulsant
action
57. 3) TBPS (t- butylbicyclophosphorothionate) binding
assay
TBPS convulsant, blocks GABAergic transmission by interacting
with picrotoxin sensitive site
Inhibition of TBPS binding to channel by test compounds
used for screening of anticonvulsant drugs
58. • Excessive excitatory neurotransmission implicated in
neuropathogenesis of epilepsy.
1) CPP (3-(2-carboxypirazin-4-yl)-propyl-1-phosphonic acid )
binding assay : Asses affinity of compounds for glutamate
binding site
2) TCP [1-(2-thienyl)cyclohexyl]-piperidine] binding assay :
used for determining the binding affinity of
noncompetitive NMDA receptor antagonist.
3) Glycine binding assay
59. Chemically induced
models
• Pilocarpine induced SE
• Li-Pilocarpine induced
• Li- methomyl induced
Electrically induced
models
• Stimulations in the
hippocampal
prefrontal pathway
Photosensitivity
model
• Photosensitive
baboon- stimulation
by stroboscope
64. Exposure of zebrafish larvae to ginkgotoxin
Seizure-like swimming behavior that is reversed by commonly
used anti-epileptic drugs
Provides system for addressing a proposed mechanism of seizure
involving GABA
65. Neuropeptide Y plays a major role in seizure control.
Mice lacking the NYP gene experience spontaneous seizures.
Strategies for NYP gene therapy may develop towards focal
epilepsies targeting Y2 receptor activation.
66. A molecular genetic tool to treat neurological conditions like
epilepsy.
Neuronal silencing approach – acting selectively on NpHR (
Halorodopsin, a light sensitive Cloride pump that can
hyperpolarize a neuron when stimulated )
Optogenetic strategies could be relevant for certain types of focal
seizures.
67. Models used for anti epileptic screening – vivo/vitro
Most common Animals used: Mice, rat
also cat, guinea pig, gerbil,
hamster
MES, PTZ & Kindling are common models
MES- GTC- Phenytoin, phenobarb
PTZ- Petit mal epilepsy – ethosuximide, valproate
Kindling- time consuming-but looks process of
epileptogenesis
Kindled seizure and kindling process – Phenobarb, Diazepam,
Valprate
68. Genetic models- best
Vitro models
Models of SE – Chemically induced, electrically induced,
photosensitivity models
Animal models for drug resistant epilepsy
Recent advances - Zebra fish, NYP gene therapy, optogentics
69. References
• Vogel’s- Drug discovery & evaluation; 3rd edition
• S K Gupta-Drug screening methods. 2nd edition
• Loscher W. Critical review of current animal models of seizure
and epilepsy used in discovery and development of new
antiepileptic drugs. Seizure. 2011;20:359-68
• Magalhães DM, Pereira N, Rombo DM, Beltrão-Cavacas C,
Sebastião AM, Valente CA. Ex vivo model of epilepsy in
organotypic slices—a new tool for drug screening.
Journal of neuroinflammation. 2018 Dec;15(1):203.
70. • Lee et al. Zebrafish larvae exposed to ginkgotoxin exhibit seizurelike
behavior that is relieved by pyridoxal-5-phosphate, GABA and anti-
epileptic drugs. Disease Models & Mechanisms. 2012;5:785-95
Sørensen AT, Kokaia M. Novel approaches to epilepsy
treatment. Epilepsia. 2013 Jan;54(1):1-0.
Löscher W, Brandt C. Prevention or modification of
epileptogenesis after brain insults: experimental
approaches and translational research. Pharmacological
reviews. 2010 Dec 1;62(4):668-700.
Convulsions – sudden, irregular movement of the body caused by involuntary movements of muscles associated with epilepsy or toxins or fever.
Stunning behaviour - in which animal remains stationary in upright position for 10 sec or more
Illustration of the collection of hippocampal tissues. With some practice, the following procedure takes as little as 15 min from decapitation of the animal to placing the cultures in the incubator. Brains are collected and prepared (a-c), and hippocampi are removed (d-f). Once the tissue chopper is ready (g), the hippocampi are chopped (h), transferred to fresh dissection medium (i), and slices are separated (j). Ideal slices (k) have a compact and clearly visible dentate gyrus granule cell body layer (D) and pyramidal neuron cell body layers (CA3 and CA1). Slices are then placed on tissue culture inserts (l) for short-term or long-term culture in a CO2 incubator.